"America's public enemy number one in the United States is drug abuse. In order to fight and defeat this enemy, it is necessary to wage a new, all-out offensive." -- President Richard Nixon, June 17, 1971
The phrase "War on Drugs" encapsulates the most aggressive and consequential escalation of drug prohibition in world history. Beginning with President Richard Nixon's formal declaration in 1971, the United States -- and subsequently much of the world -- pursued a strategy of criminalization, incarceration, and interdiction that would cost trillions of dollars, imprison millions of people, devastate communities of color, and suppress scientific research on cannabis for an entire generation. Yet this same period also witnessed the birth of the medical cannabis movement that would ultimately begin to reverse the prohibition established in the 1930s.
✅ Note This article covers the War on Drugs from 1970 through approximately 2000. For the earlier prohibition period, see The Prohibition Era. For the legalization movement, see Modern Legalization.
The Comprehensive Drug Abuse Prevention and Control Act of 1970 (Public Law 91-513), and particularly its Title II -- the Controlled Substances Act (CSA), established the federal drug classification system that remains in place today. The CSA created five "schedules" for controlled substances, ranking them by their perceived medical utility and potential for abuse.
| Schedule | Criteria | Examples |
|---|---|---|
| Schedule I | High potential for abuse; no currently accepted medical use in treatment in the United States; lack of accepted safety for use under medical supervision | Cannabis, heroin, LSD, MDMA, psilocybin |
| Schedule II | High potential for abuse; currently accepted medical use with severe restrictions; abuse may lead to severe psychological or physical dependence | Cocaine, morphine, oxycodone, methamphetamine, fentanyl |
| Schedule III | Potential for abuse less than Schedules I and II; currently accepted medical use; abuse may lead to moderate or low physical dependence or high psychological dependence | Anabolic steroids, codeine with aspirin/acetaminophen, ketamine |
| Schedule IV | Low potential for abuse relative to Schedule III; currently accepted medical use | Alprazolam (Xanax), diazepam (Valium), tramadol |
| Schedule V | Low potential for abuse relative to Schedule IV; currently accepted medical use | Preparations containing limited quantities of certain narcotics (e.g., cough preparations with codeine) |
Cannabis was placed in Schedule I -- the most restrictive category -- alongside heroin and LSD. This classification asserted that cannabis:
This classification was scientifically and historically problematic:
The Schedule I classification of cannabis had far-reaching consequences for scientific research, medical practice, and criminal justice.
In 1971, Nixon established the National Commission on Marihuana and Drug Abuse, chaired by former Pennsylvania Governor Raymond P. Shafer. The commission was tasked with studying cannabis and making policy recommendations.
The commission's first report, Marihuana: A Signal of Misunderstanding (1972), reached conclusions that directly contradicted the Schedule I classification and the broader War on Drugs framework:
President Nixon publicly rejected the Shafer Commission's findings before they were even released. He had commissioned the report expecting it to support his existing prohibition policies, and when it did not, he dismissed it. The commission's recommendations were never implemented.
This episode is one of the most revealing moments in drug policy history: a president appointed a commission to study cannabis, the commission recommended decriminalization based on evidence, and the president rejected the findings because they conflicted with his predetermined policy position.
✅ Historical Significance The Shafer Commission episode demonstrates that the escalation of the War on Drugs was not driven by scientific evidence or public health considerations. The commission's own research contradicted the administration's position, yet the policy continued unchanged. This pattern would repeat throughout the War on Drugs era.
In 1973, President Nixon created the Drug Enforcement Administration (DEA) by executive order, consolidating multiple federal drug enforcement agencies into a single organization with broad authority. The DEA was given responsibility for:
The DEA's dual role -- as both law enforcement agency and regulatory body for substance scheduling -- created a structural conflict of interest that persists to this day. The agency responsible for arresting drug users and dealers is also the agency that determines whether a substance has medical value. This arrangement has been criticized by legal scholars, medical professionals, and drug policy reformers.
Under the CSA, the DEA -- in coordination with the Department of Health and Human Services (HHS) -- determines the scheduling of controlled substances. The process for rescheduling a substance is notoriously difficult:
This process has been used to block cannabis rescheduling repeatedly over five decades. Multiple petitions to reschedule cannabis have been filed, all rejected or still pending after years of bureaucratic delay. See Modern Legalization for the eventual partial reforms of this process.
The Anti-Drug Abuse Act of 1986 (Public Law 99-570), signed by President Ronald Reagan, established mandatory minimum sentences for drug offenses. Key provisions included:
The crack/powder cocaine disparity was particularly significant because crack cocaine was disproportionately used by African Americans, while powder cocaine was more common among white users. The 100:1 ratio meant that an African American crack offender received the same sentence as a white powder cocaine offender possessing 100 times the amount. This disparity was not reduced until the Fair Sentencing Act of 2010 (reducing it to 18:1) and was never fully eliminated.
Starting in the 1990s, many states adopted "three-strikes" sentencing laws requiring life imprisonment for individuals convicted of a third serious offense. In many states, drug offenses counted as "strikes," leading to life sentences for non-violent drug offenders. The most famous case is that of Leandro Andrade, who received two consecutive 25-years-to-life sentences under California's three-strikes law for stealing $153 worth of videotapes -- his prior strikes being drug-related.
The impact of these policies on the American prison system was staggering:
| Year | Federal Prison Population | Drug Offenders (% of federal prisoners) | Cannabis Offenders |
|---|---|---|---|
| 1970 | 24,000 | ~25% | ~2,000 |
| 1980 | 52,000 | ~25% | ~5,000 |
| 1990 | 97,000 | ~50% | ~25,000 |
| 2000 | 173,000 | ~55% | ~40,000 |
| 2010 | 219,000 | ~50% | ~30,000 |
Data from Bureau of Justice Statistics and FBI Uniform Crime Reports.
The total number of individuals incarcerated for cannabis offenses in the United States since 1970 exceeds 500,000. The vast majority of these arrests were for possession, not sale or distribution.
Decades of data demonstrate that drug law enforcement has produced stark racial disparities:
The racial disparities in drug enforcement have had systemic consequences:
These disparities are well-documented in sociological research. The political motivations behind the War on Drugs were confirmed by John Ehrlichman, Nixon's domestic policy chief, in a 1994 interview with journalist Dan Baum (published in Harper's Magazine, March 24, 2016):
"The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and black people. You understand what I'm saying? We knew we couldn't make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Yes, we did."
The Nixon administration's own records have corroborated much of Ehrlichman's account. White House tapes from 1971 reveal Nixon making explicitly racialized statements about drug enforcement, and his domestic policy advisor Charles Colson recorded Nixon describing drug policy in terms of targeting political enemies. While some Nixon aides have contested the framing of Ehrlichman's remarks, the documented policy outcomes -- the racial targeting of enforcement, the rejection of the Shafer Commission's evidence-based recommendations, and the subsequent decades of disproportionate incarceration of Black Americans for drug offenses -- speak for themselves regardless of any single individual's stated intent.
The War on Drugs extended far beyond American borders. In Colombia, the cocaine trade of the 1970s and 1980s produced powerful criminal organizations (the Medellin and Cali cartels) that challenged the Colombian state itself. The United States provided billions of dollars in military aid to Colombia, including:
Plan Colombia reduced coca cultivation but at enormous human and financial cost. It displaced hundreds of thousands of civilians, failed to significantly reduce the cocaine supply (the "balloon effect" -- suppression in one area simply shifted production to another), and entrenched military influence over Colombian politics.
The United States government's relationship with drug trafficking organizations during the War on Drugs era presents one of the most damning contradictions in modern American history: while arresting and imprisoning millions of Americans for drug offenses, US intelligence agencies actively facilitated and protected drug trafficking operations when they served geopolitical objectives.
During the 1980s, the CIA-backed Contra rebels in Nicaragua financed their operations through cocaine trafficking into the United States. This was extensively documented by:
During the Vietnam War era, the CIA's proprietary airline Air America was documented transporting opium and heroin in Southeast Asia. The airline served as the primary air transport in Laos, where Hmong forces allied with the CIA controlled the opium-producing regions of the Golden Triangle. Multiple sources, including Professor Alfred McCoy (The Politics of Heroin: CIA Complicity in the Global Drug Trade, 1972, updated 1991), documented that:
The US government's tolerance for drug trafficking by its intelligence assets -- while simultaneously waging an increasingly brutal domestic drug war against American communities -- demonstrates that the War on Drugs was never primarily about public health or even drug suppression. It was about power, racial control, and geopolitical objectives.
Mexico became the primary battleground of the international drug war in the 2000s. Mexican cartels, which controlled the trafficking routes into the United States, fought violent wars against each other and against the Mexican state. President Felipe Calderon (2006 -- 2012) deployed the Mexican military against the cartels, producing a level of violence that resulted in an estimated 300,000+ deaths over his tenure and beyond (cumulative estimates through the 2020s exceed 350,000 to 400,000 when including disappearances and indirect deaths).
The Mexican drug war was, in significant part, a consequence of American drug demand and American prohibition policy. The enormous profits generated by the illicit drug market (estimated at $10-30 billion annually for Mexican cartels from the US market alone) fueled the cartel organizations' power. But the US government's responsibility extended far beyond consumer demand:
See Modern Legalization for the argument that legalization and regulation would undermine cartel economics.
While Afghanistan is primarily associated with opium production, cannabis (particularly hashish) has also been a significant crop. The Taliban and other armed groups have derived revenue from cannabis production and trafficking. US and NATO military operations in Afghanistan have included counternarcotics operations, though with limited success. The 20-year US military presence in Afghanistan (2001 -- 2021) failed to meaningfully reduce drug production, despite the expenditure of hundreds of billions of dollars -- further demonstrating the fundamental failure of the drug war model.
The international drug control treaty system, administered by the United Nations Office on Drugs and Crime (UNODC), constrains national drug policy through three treaties. These treaties were not the product of global consensus based on scientific evidence -- they were driven by US diplomatic pressure and economic coercion:
These treaties require signatory nations to criminalize cannabis possession, sale, and production (except for limited medical and scientific purposes). Countries wishing to legalize cannabis face the challenge of treaty withdrawal or renegotiation. Uruguay and Canada navigated this challenge when they legalized cannabis nationally. But the deeper consequence has been that dozens of nations -- particularly in the Global South -- were forced into prohibition frameworks that contradicted their own cultural traditions, medical practices, and policy preferences. Nations that resisted faced economic retaliation, aid reduction, and diplomatic isolation from the United States. See Modern Legalization for details.
The Schedule I classification of cannabis created enormous barriers to scientific research:
The restriction on cannabis research had direct consequences for patient care:
The scientific community has widely criticized these research restrictions. The Institute of Medicine (now the National Academy of Medicine) acknowledged in a 1999 report that cannabis could serve as a short-term treatment for certain conditions, while noting the need for more research.
The AIDS epidemic of the 1980s and 1990s was the catalyst for the modern medical cannabis movement. AIDS patients suffered from:
Cannabis was known to address all of these symptoms. AIDS patients discovered -- often through informal networks -- that cannabis could help them eat, maintain weight, and manage pain. But because cannabis was illegal, patients who were already facing a terminal diagnosis were also facing potential criminal prosecution.
Dennis Peron (1945 -- 2018) was a San Francisco activist who became the central figure in the medical cannabis movement. Peron operated the San Francisco Cannabis Buyers Club (1992), one of the first organized medical cannabis distribution operations in the United States. His partner, Jonathan West, died of AIDS in 1990, and Peron credited cannabis with improving West's quality of life during his illness.
Peron's activism was driven by a simple argument: if cannabis could help dying people eat, reduce their pain, and improve their quality of life, then denying them access to it was cruelty, not medicine.
The breakthrough came in California with Proposition 215, the Compassionate Use Act of 1996. The proposition, spearheaded by Peron and a coalition of activists, physicians, and patients, did the following:
Proposition 215 passed with 55.6% of the vote on November 5, 1996. California became the first US state to legalize medical cannabis, directly challenging the federal government's Schedule I classification and the entire framework of the War on Drugs.
The passage of Proposition 215 ignited a state-by-state movement that would, over the next two decades, lead to medical cannabis legalization in the majority of US states and eventually to full recreational legalization. See Modern Legalization for the full story.
The World Health Organization (WHO) has historically taken a cautious position on cannabis, reflecting the international treaty framework. However, in 2018, the WHO's Expert Committee on Drug Dependence recommended that cannabis be removed from the most restrictive schedule of the 1961 Single Convention, acknowledging its therapeutic value and lower abuse potential than many other controlled substances. This recommendation triggered a UN rescheduling process.
The UNODC has been the primary enforcer of the international drug control treaty system. Its position has historically been one of strict prohibition, though in recent years the organization has acknowledged the challenges posed by the global legalization movement and the need for evidence-based drug policy.
The financial cost of the War on Drugs has been enormous:
| Category | Estimated Cost (US) |
|---|---|
| Federal drug control spending (annual, 2000s) | $15-20 billion per year |
| Cumulative federal spending (1971-2020) | Over $1 trillion |
| State and local spending (annual) | $25-30 billion per year |
| Incarceration costs (annual) | $80+ billion (all crimes, with drug offenses representing a significant portion) |
| Lost tax revenue from illicit market | $10-20 billion annually (estimated) |
| Economic impact of collateral consequences | Hundreds of billions (lost productivity, intergenerational effects) |
These costs must be weighed against the outcomes: drug availability has not significantly decreased, drug-related deaths have increased (particularly from synthetic opioids), and the social costs of mass incarceration continue to compound. See Modern Legalization for the economic argument for legalization and regulation.
| Date | Event | Significance |
|---|---|---|
| 1970 | Controlled Substances Act passed | Cannabis placed in Schedule I |
| 1971 | Nixon declares "War on Drugs" | Formal policy announcement |
| 1972 | Shafer Commission recommends decriminalization | Findings rejected by Nixon |
| 1973 | DEA created | Consolidation of federal drug enforcement |
| 1970s | Oregon decriminalizes cannabis (1973) | First state to reduce cannabis penalties |
| 1970s -- 1980s | 11 states decriminalize cannabis | Early reform movement |
| 1984 | Anti-Drug Abuse Act | Mandatory minimums introduced |
| 1986 | Anti-Drug Abuse Act (crack/powder disparity) | 100:1 sentencing ratio |
| 1980s -- 1990s | AIDS crisis accelerates | Medical cannabis movement begins |
| 1990s | Three-strikes laws proliferate | Life sentences for non-violent drug offenders |
| 1992 | San Francisco Cannabis Buyers Club opens | First organized medical cannabis distribution |
| 1996 | California Proposition 215 passes | First medical cannabis legalization |
| 1999 | Institute of Medicine report | Acknowledges cannabis's therapeutic potential |
| 2000 | Plan Colombia launched | International drug war escalation |
| 2006 | Mexican drug war begins | Estimated 300,000+ deaths cumulative through 2020s |
| 2010 | Fair Sentencing Act | Reduces crack/powder disparity to 18:1 |
The War on Drugs era (1970 -- 2000) was characterized by:
The passage of Proposition 215 in 1996 marked the beginning of the end of the prohibition era. The movement that started with dying patients demanding access to symptom relief would grow into a global legalization movement that transformed the legal landscape of cannabis worldwide. See Modern Legalization & Renaissance for the continuation of this story.
The policies enacted during the War on Drugs era continue to shape cannabis law today. For detailed coverage of how these policies have evolved — and the jurisdictions working to reverse their harms — visit the Law & Policy section:
| Page | Description |
|---|---|
| The Prohibition Era | The foundations of cannabis criminalization |
| Modern Legalization | The reversal of prohibition beginning in 1996 |
| Legal Landscape | Current global cannabis legality |
| Cannabinoids Overview | The compounds whose research was suppressed |
| Science | Modern research that the War on Drugs delayed |
✅ Disclaimer This wiki is provided strictly for educational purposes. Nothing on this site constitutes medical, legal, or professional advice. Cannabis laws vary by jurisdiction and change frequently. Always consult qualified professionals and verify your local laws before taking any action based on information found here.
Last updated: April 2026 | CannaGrow is licensed under CC BY-SA 4.0.